Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ferrer

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Transplantation Proceedings|July 31, 2012
Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in SpainI Gutiérrez Domingo, J M Pascasio Acevedo, A Alcalde Vargas, et al.
Transplantation Proceedings|July 31, 2012
Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a responseI Gutierrez Domingo, J M Pascasio Acevedo, A Alcalde Vargas, et al.
Transplantation Proceedings|July 31, 2012
Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantationA Alcalde Vargas, J M Pascasio Acevedo, I Gutiérrez Domingo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2014
Prevalence and severity of hepatopulmonary syndrome and its influence on survival in cirrhotic patients evaluated for liver transplantationJ M Pascasio, I Grilo, F J López-Pardo, et al.
Transplantation Proceedings|November 18, 2008
Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in SpainS Aoufi, J M Pascasio, J M Sousa, et al.
Clinical Therapeutics|August 27, 1999
Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study GroupG Sussman, J Shurman, M R Creed, et al.
Cells|September 9, 2022
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular CarcinomaPatricia de la Cruz-Ojeda, Tobias Schmid, Loreto Boix, et al.
Plos One|March 29, 2017
Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantationRaúl González, Ángel J De la Rosa, Alessandro Rufini, et al.
Revista Espanola De Enfermedades Digestivas|November 1, 2001
Flutamide-induced hepatotoxicity: report of a case seriesM García Cortés, R J Andrade, M I Lucena, et al.
Epidemiology and Infection|July 31, 2007
A large Legionnaires' disease outbreak in Pamplona, Spain: early detection, rapid control and no case fatalityJ Castilla, A Barricarte, J Aldaz, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Transplantation Proceedings|July 31, 2012
Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in SpainI Gutiérrez Domingo, J M Pascasio Acevedo, A Alcalde Vargas, et al.
Transplantation Proceedings|July 31, 2012
Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a responseI Gutierrez Domingo, J M Pascasio Acevedo, A Alcalde Vargas, et al.
Transplantation Proceedings|July 31, 2012
Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantationA Alcalde Vargas, J M Pascasio Acevedo, I Gutiérrez Domingo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2014
Prevalence and severity of hepatopulmonary syndrome and its influence on survival in cirrhotic patients evaluated for liver transplantationJ M Pascasio, I Grilo, F J López-Pardo, et al.
Transplantation Proceedings|November 18, 2008
Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in SpainS Aoufi, J M Pascasio, J M Sousa, et al.
Clinical Therapeutics|August 27, 1999
Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study GroupG Sussman, J Shurman, M R Creed, et al.
Cells|September 9, 2022
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular CarcinomaPatricia de la Cruz-Ojeda, Tobias Schmid, Loreto Boix, et al.
Plos One|March 29, 2017
Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantationRaúl González, Ángel J De la Rosa, Alessandro Rufini, et al.
Revista Espanola De Enfermedades Digestivas|November 1, 2001
Flutamide-induced hepatotoxicity: report of a case seriesM García Cortés, R J Andrade, M I Lucena, et al.
Epidemiology and Infection|July 31, 2007
A large Legionnaires' disease outbreak in Pamplona, Spain: early detection, rapid control and no case fatalityJ Castilla, A Barricarte, J Aldaz, et al.
Pageof 11